| Disease | post-traumatic stress disorder |
| Phenotype | C0497327|dementia |
| Sentences | 1 |
| PubMedID- 26310190 | In several countries, brexpiprazole is in development for mdds, schizophrenia, post-traumatic stress disorder and agitation in patients with dementia of the alzheimer's type. |
Page: 1